It will be important to investigate if there is a direct and inverse correlation between sortilin and syndecan-1 and to establish if there is either a molecular switch or an alternative mechanistic explanation for the alignment of these biomarkers with different stages of prostate cancer progression. Here, SDC1 is linked to prostate cancer.